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Vascular smooth muscleβ1 integrin has been shown to contribute to vascular smooth muscle cell differentiation, adhesion and
mechanosensation in vitro. Here we showed that deletion of β1 integrin at the onset of smooth muscle differ-
entiation resulted in interrupted aortic arch, aneurysms and failure to assemble extracellular matrix proteins.
These defects result in lethality prior to birth. Our data indicates that β1 integrin is not required for the ac-
quisition, but it is essential for the maintenance of the smooth muscle cell phenotype, as levels of critical
smooth muscle proteins are gradually reduced in mutant mice. Furthermore, while deposition of extracellu-
lar matrix was not affected, its structure was disrupted. Interestingly, defects in extracellular matrix and vas-
cular wall assembly, were restricted to the aortic arch and its branches, compromising the brachiocephalic
and carotid arteries and to the exclusion of the descending aorta. Additional analysis of β1 integrin in the
pharyngeal arch smooth muscle progenitors was performed using wnt1Cre. Neural crest cells deleted for
β1 integrin were able to migrate to the pharyngeal arches and associate with endothelial lined arteries;
but exhibited vascular remodeling defects and early lethality. This work demonstrates that β1 integrin is dis-
pensable for migration and initiation of the smooth muscle differentiation program, however, it is essential
for remodeling of the pharyngeal arch arteries and for the assembly of the vessel wall of their derivatives.
It further establishes a critical role of β1 integrin in the protection against aneurysms that is particularly con-
ﬁned to the ascending aorta and its branches.
© 2012 Elsevier Inc. All rights reserved.Introduction
The assembly of the vascular wall during development occurs
through the rapid investment of endothelial tubes by mesenchymal
cells and their progressive differentiation into smooth muscle cells
(Drake et al., 1998; Hungerford and Little, 1999; Owens, 1995). During
this process, vascular smooth muscle cells (vSMCs) secrete and organize
layers of extracellular matrix proteins that quickly intertwine with
smooth muscle cells to generate a highly integrated tissue able to re-
spond to and regulate intravascular pressure (Gasser et al., 2006; Jones
et al., 1979; Li et al., 2003; Wagenseil and Mecham, 2009). The various
extracellular matrix (ECM) components are critical to the integrity of
the wall, as the smooth muscle cells themselves are not sufﬁcient toe, UCLA, 615 Charles E. Young
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rights reserved.comply with the constant mechanical stress imposed by the pulsatile
bloodﬂow(Wagenseil andMecham, 2009). Humanmutations inﬁbrillin
1 (FBN1) or type III α1 collagen (COL3A1) genes cause Marfan and
Ehlers-Danlos syndromes respectively and result in aortic aneurysms,
an abnormal enlargement of the aorta caused by thinning of the vessel
wall (Dietz et al., 1991; Dietz and Pyeritz, 1995; Pope et al., 1975). Fur-
thermore, mouse models that lack Fbn1, ﬁbulin 4 (FBLN4) and biglycan
(BGN) also led to the development of aneurysms in the aorta
(Heegaard et al., 2007; Maki et al., 2002; McLaughlin et al., 2006;
Pereira et al., 1997). Likewise, genetic mutations in smooth muscle con-
tractile proteins were noticed to be responsible for hereditary vascular
anomalies (Guo et al., 2007; Pannu et al., 2007; Zhu et al., 2006). For ex-
ample, missense mutations in α actin (ACTA2) were found to be associ-
ated with 14% of inherited aortic dissections (Guo et al., 2007). More
recently, heterozygous mutations in smooth muscle myosin heavy
chain (MYH11) were identiﬁed in kindreds with a wide variety of vascu-
lar anomalies, including patent ductus arteriosus, thoracic aortic aneu-
rysms and aortic dissections (Pannu et al., 2007; Zhu et al., 2006). Thus,
it is clear that the pathobiological processes that lead to the development
of aneurysms include abnormalities in either vascular ECM proteins,
vSMC or in a combination of both.
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connects the extracellular matrix to the actin cytoskeleton and is
thought to participate in vSMC differentiation, ECM organization
and mechano-sensing in vivo (Hynes, 2002; Li et al., 2003; Sun et
al., 2005; Xiao et al., 2007). While many of the integrins have been
shown to contribute to vSMC function in vitro, β1 integrin is consid-
ered to play a particularly signiﬁcant role as it partners with multiple
α subunits and thus constitutes a highly represented receptor
(Martinez-Lemus et al., 2003). Furthermore, in vitro studies demon-
strated that β1 integrin is important for the differentiation of stem
cells into smooth muscle and in the organization of collagen and ﬁ-
bronectin ﬁbers (Li et al., 2003; Xiao et al., 2007). Though in vitro
and ex vivo studies are informative, these studies cannot fully recapit-
ulate the in vivo context.
Global inactivation of β1 integrin results in peri-implantation em-
bryonic lethality around embryonic day 5.5 (E5.5), several days prior
to smooth muscle cell differentiation in the embryo (Fassler and
Meyer, 1995; Stephens et al., 1995). Consequently, cell-speciﬁc dele-
tion experiments through Cre-lox systems have been critical to eluci-
date the speciﬁc contributions of this gene within a cellular
compartment. To determine the role of β1 integrin in differentiated
smooth muscle cells, we independently crossed two different β1
integrin ﬂox alleles to the sm22αCre recombinase mouse (Holtwick
et al., 2002). The use of the sm22α ensured that deletion occurred
in a population of cells that were committed to the smooth muscle
fate and had initiated their differentiation program. Mutant mice
were embryonic lethal at late gestation and exhibited interrupted
aortic arch, aneurysms and failure to assemble ECM proteins. Interest-
ingly, the phenotype was mostly conﬁned to the branches of the aor-
tic arch and compromising the brachiocephalic and carotid arteries.
The defects did not extend to the dorsal aorta. Deletion of β1 integrin
in neural crest using the wnt1Cre conﬁrmed that absence of the pro-
tein did not affect migration of smooth muscle precursors to the aor-
tic arch. These ﬁndings establish a critical period in development
(E15.5 to E18.5) that requires β1 integrin for the assembly of the vas-
cular wall. The data also highlights an essential contribution of β1
integrin in the protection against aneurysms that is conﬁned to the
ascending aorta and emerging/proximal carotid arteries.
Materials and methods
Mice
β1e3 (Raghavan et al., 2000), sm22αCre (Holtwick et al., 2002) and
wnt1Cre (Danielian et al., 1998) mice were purchased from Jackson
Labs. We also used the previous published β1ﬂ mouse (Potocnik et al.,
2000). Cre recombinase expressing mouse lines were independently
bred to the β1ﬂ and β1e3 transgenic lines. Additionally, β1e3;
sm22αCre+and β1e3; wnt1Cre mice were crossed to the ROSA26R
(Soriano, 1999) line, also obtained from Jackson Labs. Genotyping for
these lines was performed as previously described (Turlo et al., 2010;
Zovein et al. 2010). The vaginal plug in conjunction with developmental
stagingwas used to determine the embryonic age of the embryos evalu-
ated. Experimentswere evaluated and approved by the Animal Research
Committee at the University of California, Los Angeles.
Histological analysis
β-galactosidase staining was performed as described previously
(Turlo et al., 2010). Immunostaining for β1 integrin on the β1ﬂ dorsal
aorta was done on vibratomed sections without an unmasking step.
Tissue was dissected and placed in 2% paraformaldehyde overnight.
Sections were obtained after the tissue was embedded in agarose
and vibratomed into 300–500 μm sections. Specimens were then
rinsed in 1X PBS and placed in blocking solution (1x PBS pH7.8, 5%
donkey serum, 0.3% triton) for 1 h. Next, sections were incubated inblocking buffer with primary antibody overnight following standard
immunostaining techniques as previously described (Zovein et al.,
2010). All other immunostaining was performed on histological sec-
tions also following protocols described (Zovein et al. 2010, for de-
tailed protocols visit: http://www.mcdb.ucla.edu/Research/Arispe/
index.php). Unmasking of epitopes was done in 10 mM sodium cit-
rate at pH 6.0 and heated to 100 °C for 15 min. Sections were blocked
in 5% donkey serum in 1X PBS with 0.3% triton. Antibodies used in
immunostaining were β1 integrin (1:100, Millipore, MAB 1997),
FITC-α-smooth muscle actin (1:200, Sigma, F3777), myh11 (1:200,
ABD Serotec), calponin (1:200, Abcam), tropoelastin (1:200,
abcam), ﬁbronectin (1:200, abcam), laminin (1:200, Sigma), collagen
IV (1:200, abd serotec) and sm22α (1:200, Abcam). Samples were
imaged using a 10×, 40× or 100× objective in a Zeiss LSM 510
META confocal microscope.
Western blot
For Western blots on E15.5 and P(0) animals, the whole thoracic
aorta was extracted in RIPA buffer (Lee et al., 2006). Tissue for Western
blot of E10.5 embryos was collected from the pharyngeal arch region of
the embryo. Tissue was ﬁrst snap frozen and subsequently extracted in
RIPA buffer. Total protein concentrationswere obtained using DC protein
assay (Bio-Rad) on the Bio-Rad Molecular imager Chemi Doc XRS+
using Image Lab Software v3. Equal total protein levels (generally 5–
10 μg) were loaded per lane. Antibodies used for Westerns included:
β1 integrin (1:1000, Millipore, AB1952), α-tubulin (1:1000, Sigma,
T5168), GAPDH (1:5000, Millipore, MAB374) and α-smooth muscle
actin (1:5000, Sigma, A2547).
Results
Deletion of β1 integrin in smooth muscle results in perinatal/early
postnatal death
While the expression of β1 integrin in mature vSMCs is well estab-
lished (Mechtersheimer et al., 1994), the initiation of β1 integrin ex-
pression in this cell population has not been characterized. Thus, we
crossed mice carrying the β1 integrin loxP ﬂanked allele (β1ﬂ) that
includes a lacZ reporter to mice with the sm22αCre (sm) transgene
(Fig. 1A) (Holtwick et al., 2002; Potocnik et al., 2000). Excision of
the DNA between the loxP sites concurrently results in genetic dele-
tion and reporter activation providing a faithful read-out of β1 integ-
rin promoter activity. We chose to use the sm22αCre as this gene is
expressed at the onset of smooth muscle differentiation (Yang et al.,
2010). From this cross we found β-galactosidase (β-gal) positive
cells are present as early as E9.5 in the dorsal aorta and heart
(Fig. 1B). By E15.5 all smooth muscle cells of the aortic arch and ca-
rotids are positive for β-gal (Fig. 1C). This expression persists into
maturity and it includes all smooth muscle cells in the vessel wall
suggesting a constitutive need for this gene in vSMC even after devel-
opment has ceased (Fig. 1D). In addition to vSMCs, staining for β-gal
in smR26R and smβ1ﬂ/wt embryos conﬁrmed sm22αCre also targets
early cardiomyocytes, where the β1 integrin promoter is active as
early as E8.5 (Figs. 1B, C and Fig. S1). Overall, we found that expres-
sion of β1 integrin essentially mirrors the sm22α promoter, as per
ROSA26R β-gal evaluations (data not shown).
In addition to functioning as a reporter of β1 integrin promoter ac-
tivity, the β1ﬂ allele also promotes deletion of β1 integrin. Generation
of smβ1ﬂ/ﬂ mice revealed that these mice died embryonically or
shortly after birth. No live animals with the mutation were found
after postnatal day 5 [P(5)] (Table 1). At the neonate stage, smβ1ﬂ/ﬂ
animals were easily recognized among their wild type littermates,
as per their pale appearance (Fig. S3A). Previous work by our lab
revealed differences in phenotypes depending on the β1 integrin
Fig. 1. Expression and deletion of β1 integrin. A) Schematic of the β1 integrin loxP ﬂanked constructs. B–D) Whole mount and histological representation of lacZ expression in the
pharyngeal arches (B), aortic arch and carotids in smβ1ﬂ/wt embryos at E9.5, E15.5 and 8 weeks. (arrows=lacZ positive cells; H = heart, DA = dorsal aorta) E) Western blot show-
ing a reduction in β1 integrin in the dorsal aorta at P(0) in the smβ1ﬂ/ﬂ (K) when compared to the β1ﬂ/ﬂ (W) and at E15.5 in the smβ1e3/e3 (K) against the β1e3/e3 (W). F) Immu-
noﬂuorescence of β1 integrin (red), α-smooth muscle actin (green) and topro (blue) in the dorsal aorta at P(0) in the β1ﬂ/ﬂ and the smβ1ﬂ/ﬂ (white arrows=endothelium; brackets
indicate region of smooth muscle). G) Immunoﬂuorescence of β1 integrin (red), α-smooth muscle actin (green) and torpo (blue) in the dorsal aorta at E15.5 in the β1e3/e3 and the
smβ1e3/e3 (white arrows=endothelium; brackets indicate region of smooth muscle).
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more comprehensive insight into β1 integrin deletion, we crossed the
sm22αCre mouse to a second β1 integrin loxP allele (β1e3, Fig. 1A)
(Raghavan et al., 2000). In this model, no Cre positive smβ1e3/e3 mice
survived past parturition (Table 1).Western blot analysis of β1 integrin
in the dorsal aorta for both alleles, smβ1ﬂ/ﬂ at P(0) and smβ1e3/e3 at
E15.5, conﬁrmed that both models resulted in signiﬁcant reduction of
β1 integrin protein levels (Fig. 1E). This was further veriﬁed by immu-
noﬂuorescence of β1 integrin in the dorsal aorta and carotid where β1
integrin expressionwasmaintained in the endothelium (white arrows)
of smβ1ﬂ/ﬂ and smβ1e3/e3 while a signiﬁcant reduction to complete loss
of protein was noted in the smooth muscle (Figs. 1F–G and Fig. S2).
β1 integrin is essential for cardiomyocyte proliferation, remodeling and
structural integrity of the aortic arches
Cre-recombinase activity was mapped using the ROSA26 reporter
early in development (E 9.5) and found to target both cardiomyocytes
and vascular smooth muscle cells (Figs. 1B–D, Fig. S1). Examination of
mutant mice (smβ1ﬂ/ﬂ) at P(0), revealed cyanosis that was consistent
with multiple sites of hemorrhage in the epicardium (Fig. S3E [black
arrows]). These hemorrhages were present in over 80% of E18.5
smβ1ﬂ/ﬂ animals and were also seen in embryonic smβ1e3/e3 knock-
outs (Fig. S3F, S4A [black arrows], S4D [black arrows] and S4E). Histo-
logical evaluation of the smβ1e3/e3 hearts denoted further anomalies
(Fig. S4A and S4D). Incomplete ventricular septum was found in allof the smβ1e3/e3 animals examined for this defect (E15.5, n=5; Fig.
S4A [red arrows]). In contrast control β1e3/e3 littermates exhibited fu-
sion of the ventricular septum (Fig. S4A; n=4). By E18.5, the ventric-
ular septal defects resolved (Fig. S4D) and the hemorrhages in the
epicardium were less prominent (Fig. S4D [black arrow]).
The ventricular septal defect at E15.5 and the overall size of the
smβ1e3/e3 hearts suggested a signiﬁcant developmental delay. This
data corroborates a previous report indicating deletion of β1 integrin
impairs proliferation in developing cardiomyocytes, albeit that study
was done with a distinct Cre line (Ieda et al., 2009). We conﬁrmed re-
duced proliferative capacity in the smβ1e3/e3 particularly within the
ventricular septum (Fig. S4B). As a result of this reduced proliferation,
the hearts of the smβ1e3/e3 were smaller than the β1e3/e3 controls at
E15.5 and E18.5 (Fig. S4A and S4C).
In addition to the cardiac defects, smβ1ﬂ/ﬂ and smβ1e3/e3 embryos
exhibited several anomalies in the large vessels emanating from the
heart. Both mice showed frequent aneurysms in the carotids and oc-
casional defects in the aortic arch near the left common carotid
branch (Figs. 2A–B, S3B-D). Aneurysms were noted at both E15.5
and 18.5 with the defect being more pronounced at later develop-
mental stages (Fig. 2A). In addition, poor extension of the carotids be-
tween aorta and internal and external carotid branch point was a
commonly noted phenotype (Fig. 2A [E18.5, green arrow]). At E15.5
more than 60% of the smβ1e3/e3 were found to have either aortic
arch or carotid aneurysms or an interrupted aortic (Fig. 2B). By
E18.5, 79% of animals showed defects (13% interrupted aortic arch,
Table 1
Embryonic and neonate survival of control and β1 deleted smooth muscle or neural
crest micea.
smβ1ﬂ/wt X β1ﬂ/ﬂ
sm22αCre Cre-
β1ﬂ/ﬂ β1ﬂ/wt β1ﬂ/ﬂ β1ﬂ/wt
E9.5 2 3 0 3
E10.5 1 4 0 2
E15.5 12 16 13 11
E16.5 4 0 3 2
E18.5 14 16 5 13
P(0) 59 113 126 103
P(5) 0 4 2 5
smβ1e3/wt X β1e3/e3
sm22αCre Cre-
β1e3/e3 β1e3/wt β1e3/e3 β1e3/wt
E9.5 15 14 10 12
E10.5 13 17 9 7
E11.5 7 3 2 4
E12.5 3 5 7 7
E15.5 31 28 28 29
E18.5 17 15 13 28
P(0) 0 5 6 9
ncβ1ﬂ/wt X β1ﬂ/ﬂ
Wnt1Cre Cre-
β1ﬂ/ﬂ β1ﬂ/wt β1ﬂ/ﬂ β1ﬂ/wt
E9.5 1 1 2 3
E10.5 1 2 3 1
E12.5 5 3 3 6
E15.5 9 10 10 7
P(0) 2 4 1 3
ncβ1e3/wt X β1e3/e3
Wnt1Cre Cre-
β1e3/e3 β1e3/wt β1e3/e3 β1e3/wt
E9.5 14 10 13 7
E10.5 24 23 17 23
E11.5 1 6 7 3
E12.5 0 2 4 1
E13.5 0 2 3 2
E15.5 0 4 8 5
E16.5 0 2 4 3
P(0) 0 2 2 1
a Numbers reﬂect live animals of speciﬁed genotype collected at the age stated.
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arch phenotype occurred in our early analysis of the smβ1e3/e3
mice, but it was later lost as the mixed background became more ho-
mogeneous. Of the smβ1ﬂ/ﬂ animals analyzed, none exhibited inter-
rupted aortic arch. The differences in phenotype between the β1ﬂ
and β1e3 models may be attributed to the differential efﬁciency in
β1 integrin deletion. Though both alleles showed a signiﬁcant de-
crease in β1 integrin protein, low levels of β1 integrin in smoothmus-
cle cells were noted in the smβ1ﬂ/ﬂ carotids, but complete loss was
documented when using the smβ1e3/e3 (Figs. S2, 1F and G). Although
the descending aorta was examined thoroughly, no dilation or thin-
ning of the wall was ever observed in either deletion model.
The remarkable restriction of the vascular defects to the aortic
arch and carotids/brachiocephalic led us to examine β1 integrin ex-
pression in this region versus the descending aorta. Western blot
analysis of β1 integrin levels in the aortic arch and descending dorsal
aorta of wild type E18.5 embryos demonstrated the aortic arch to
have elevated levels of the protein both in late embryos and in adult
mice (Fig. 2D and data not shown). For this reason we focused our at-
tention on the etiology and molecular basis of the aneurysms of the
aortic arch and carotids. Further, although both the smβ1ﬂ/ﬂ and thesmβ1e3/e3 had similar phenotypes, here we describe the β1e3 line
for sake of space. Results from the β1ﬂ line can be found in the sup-
plemental material (Fig. S9, S11, S12 and S14).
In order to understand the cellular mechanisms that resulted in vas-
cular aneurysms, we performed histological analysis at the onset of the
defects (E15.5) and a late stage (E18.5) when the vascular defects
weremore pronounced. Our systematic analysis of the dissected vessels
showed frequent, multiple dilations in the carotids and aorta (Fig. 2A).
Histological assessment conﬁrmed increased diameter and abnormal
compaction of the vesselwall (Fig. 2C). To further understand the nature
of the defect, we considered possible alterations in the number of
smoothmuscle cells. Thus,weﬁrst evaluated neural crestmigration dur-
ing investment of cells into the pharyngeal arch. This was a likely possi-
bility as β1 integrin has been shown to be required from migration in
vitro. Smooth muscle cells of the aortic arch and the base of the carotids
derive from neural crest cells thatmigrate from the dorsal portion of the
neural tube to populate the vascular media (Hiruma et al., 2002;
Majesky, 2007; Serbedzija et al., 1992). Analysis of the β-gal stained
smβ1ﬂ/wt indicates that deletion using the sm22αCre occurs around
E9.5, as neural crest cells reach the pharyngeal arches (Fig. 1B). The re-
sult is dependent on both sm22αCre activity andβ1 integrin expression.
Evaluation of sm22α (red) by immunoﬂuorescence in conjunction with
α-smooth muscle actin (green) at E10.5 demonstrates that both pro-
teins are present and further suggests that the sm22α promoter is active
in smoothmuscle/progenitor by this time (Fig. S5). It appears both at the
gross and histological level that Cre recombinase becomes active at the
pharyngeal arch artery around E9.5 and that the vessels are equally pop-
ulated by β-gal positive cells in both the smβ1e3/wt; R26R controls and
smβ1e3/e3; R26R knockouts (Fig. S1 and data not shown). From this
data, we concluded that deletion of β1 integrin in sm22αCre expressing
cells does not affect the initial populating of the aortic arch and carotids.
After migration, neural crest-derived progenitors differentiate into
vSMCs, proliferate and organize into multiple concentric layers. We
examined proliferation at both E15.5 and E18.5 and found no signiﬁ-
cant differences (Fig. S6A). Furthermore, assessment of apoptosis by
evaluation of cleaved caspase 3 staining revealed no signiﬁcant differ-
ences between both β1e3/e3 and smβ1e3/e3 (Fig. S6B). Combined, our
ﬁndings indicated that the aneurysms did not result from abnormal
apoptosis or proliferation.
A caveat in the interpretation of the vascular phenotype in these
mice is thatβ1 integrinwas alsodeleted in theheart, as per early expres-
sion of sm22α in this tissue. In order to determine whether the vascular
defects were primary or secondary to deletion of β1 integrin in the
heart, we used a third knock out model that bypasses heart deletion
and impacts the population of vSMC affected by the deletion, namely
neural crest cell derivatives.Wnt1Cre targets neural crest cells including
vSMC progenitors that populate the aortic arches (Fig. 3A) (Danielian et
al., 1998) and unlike the sm22αCre, the wnt1Cre is not active in the
heart (Fig. 3A). Previous reports of neural crest deletion of β1 integrin,
using the HtPaCre crossed to the β1ﬂ described a Hirshsprungs-like phe-
notype with insufﬁcient innervation of the colon due to reduced migra-
tion (Breau et al., 2006; Pietri et al., 2003). The animals died of
malnutrition at a later postnatal stage. We crossed the Wnt1Cre to the
β1ﬂ/wt and evaluated reporter expression by β-gal activity. At E9.5 the
entire pharyngeal arch region is targeted by the Wnt1Cre, as shown by
cells positive for β-gal (Fig. 3A). In contrast, recombination in the
smβ1ﬂ/wt in the same region and developmental stage occurs only in dif-
ferentiating cells (compare Figs. 3A and 1B). Consistent with the known
contribution of neural crest cells to the aorta; no β-gal positive cells
were detected beyond the aortic arch or posterior to the branch of the
left common carotid artery in the adult (Fig. 3A).
Evaluation of the ncβ1ﬂ/ﬂ revealed an intact aortic arch that was
grossly wild type at E15.5 (Fig. S7). Importantly, the animals survived
beyond birth as previously reported (Breau et al., 2006; Pietri et al.,
2003) (Table 1). In contrast, crosses between Wnt1Cre (nc) and the
β1e3 resulted in fully penetrant embryonic lethality by E12.5
Fig. 2. Aortic arch and carotid defects following β1 deletion in smooth muscle. A) Intact and isolated aortic arches from E15.5 and E18.5 of β1e3/e3 and smβ1e3/e3 embryos (white
arrows=dilations, black arrows=hemorrhage, red arrows=arch defects, green arrows=internal/external carotid branch, A= atria, V=ventricle, Ao=aorta, IAA= interrupted aortic
arch). B) Frequency of aneurysms and interrupted aortic arch (IAA). C) Trichrome stained histological sections of the right carotid, below the branch at E15.5 and E18.5 in β1e3/e3 and
smβ1e3/e3 embryos. D) Western blot of β1 integrin from wild type E18.5 aortic arch (AA) and dorsal aorta (DA) with α-tubulin and α-smooth muscle actin loading controls.
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we evaluated the phenotype at E10.5. At this time, point a signiﬁcant
decrease in β1 integrin was noted in the pharyngeal arches (Fig. 3E).
Deletion of β1 integrin in neural crest cells revealed pharyngeal arch
artery aneurysms that accumulate blood (Figs. 3B [white arrow], D
[black arrow]).
In order to assess migration of neural crest progenitors β1e3 mice, we
crossed the ncβ1e3/wt to the R26R reportermouse.Wholemount andhis-
tological examination for E9.5 and E10.5 of both ncβ1e3/wt; R26R controls
and ncβ1e3/e3; R26R knockouts show the location of β-gal positive cells
and the composition within the pharyngeal arches, to be equivalent
(Figs. 3C–D). While aneurysms are present in ncβ1e3/e3; R26R by E10.5,
this dilation is completely surrounded by β-gal positive cells, indicating
that neural crest cells were able to migrate albeit with signiﬁcantly re-
duced levels of β1 integrin (Fig. 3D [black arrow]). Immunoﬂuorescence
of dilated pharyngeal arch arteries showed cells expressing α-smooth
muscle actin (green) and sm22α (red), again conﬁrming neural crestmi-
gration and differentiation (Fig. S8). In addition, the pathological vascular
dilations were present in the context of a wild type heart, indicating that
the vascular defects were independent of the heart abnormalities.
The ncβ1e3/e3 data showed that a migration defect was unlikely to
contribute to the observed phenotype and immunoﬂuorescence stain-
ing indicated the defects in the carotids were not due to proliferation
or apoptosis. Now that proliferation and heart defects were discardedas contributing signiﬁcantly to the phenotype, we turned our atten-
tion to the structure of the tunica media. We evaluated serial sections
of the carotid and brachial arteries as well as the aortic arch to better
identify the extent and location of the disorganized media (Figs. 4B
and D). The thoracic dorsal aorta was sectioned independently of the
arch. Histological sections encompassing the carotids and brachial ar-
teries deleted for β1 integrin showed defects in the organization of the
vascular wall (β1e3/e3 Figs. 4A–D and β1ﬂ/ﬂ Fig. S8A–S8D). However,
sections across the aortic arch showed large portions of organized me-
dial smooth muscle and ECM. In some of the smβ1e3/e3 we were able
to identify defects in the arch at the base of the carotid branches
(Fig. 2A red arrows and S10). Whole mount arches of P(0) smβ1ﬂ/ﬂ
exhibited this defect most clearly (Fig. S3D). Sections of the descending
aorta were undistinguishable between smβ1e3/e3 and β1e3/e3 controls.Loss of β1 integrin does not alter initiation but affects maintenance of
SMC differentiation
Deletion of β1 integrin in ES cells inhibits acquisition of cardiac and
smooth muscle cell fate (Fassler et al., 1996; Xiao et al., 2010). In order
to determine the effect of β1 integrin deletion on vSMC maturation
after commitment, we evaluated arteries from smβ1e3/e3 and β1e3/e3
embryos at E15.5 and E18.5 (Figs. 5A–C and S11). By E15.5 α-smooth
Fig. 3. Characterization of β1 integrin deletion in neural crest. A) β-galactosidase stained ncβ1ﬂ/wt embryo at E9.5 and adult aortic arch (H = heart, AA = aortic arch, DA = dorsal
aorta). B) Whole mount β1e3/e3 and ncβ1e3/e3 embryos at E9.5 and E10.5. (white arrows=aneurysm) C) Whole mount and histological sections of β-galactosidase stained ncβ1e3/wt
R26R and ncβ1e3/e3; R26R embryos at E9.5. D) Whole mount and histological sections of ncβ1e3/wt; R26R and ncβ1e3/e3; R26R embryos at E10.5. (black arrow=aneurysm) E) West-
ern blot of β1 integrin with GAPDH loading control of pharyngeal arch region from E10.5 β1e3/e3 (W) and ncβ1e3/e3 (K) embryos.
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were present and expressed at approximately equivalent levels in mu-
tant and control mice. Indicating that loss of β1 integrin did not alter
the differentiation. In contrast, by E18.5 the expression of sm22α, cal-
ponin and smooth muscle myosin heavy chain were signiﬁcantly re-
duced in the smβ1e3/e3 when compared with the β1e3/e3 in the
carotid. Evaluation of the dorsal aorta also showed that calponin levels
are reduced in the smβ1e3/e3 though smooth muscle myosin heavy
chain showed a less signiﬁcant difference in expression when com-
pared to wild type descending dorsal aorta. α-Smooth muscle actin
appeared less affected by β1 integrin deletion in both the carotid and
the dorsal aorta. This data indicates smooth muscle cells are able to
complete their differentiation program in the absence of β1 integrin,
but could not sustain adequate levels for a subset of proteins associated
with the fully differentiated phenotype.The sm22α cre recombinase enabled the evaluation of β1 integrin in
themaintenance of established differentiation (Figs. S5 and 5). Thewnt1
cre recombinase provided themeans to determine if differentiation was
affected by β1 integrin deletion prior to commitment to the smooth
muscle fate (Fig. S8). This data further demonstrates that β1 integrin is
not required for the onset of differentiation, but is necessary for the
maintenance of wild type expression levels later in development.
Developmental deletion in SMCs disrupts ECM assembly
As previously reported, ECM proteins are critical to support the in-
tegrity of the vascular wall (Wagenseil andMecham, 2009). β1 integrin
has been shown to participate in organization and cross-linking of ECM
proteins (Li et al., 2003). Thus, we explored whether synthesis and/or
organization of ECM in the carotid and dorsal aorta was compromised
Fig. 4. Dilation and disorganization within the carotids and aortic arch following β1 integrin deletion in smooth muscle. A) Schematic of a β1e3/e3 aortic arch with lines (red) repre-
senting serial sections through the right (left) and left (right) carotids through the aortic arch. B) Trichrome stained serial sections of the carotids and aorta from a representative
β1e3/e3 embryo at E18.5. C) Schematic of an smβ1e3/e3 aortic arch with lines (red) representing serial sections through the right (left) and left (right) carotids through the aortic
arch. D) Trichrome stained serial sections of the carotids and aorta from a representative smβ1e3/e3 embryo at E18.5.
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gen, elastin and laminin by immunohistochemistry at E15.5 and E18.5
in β1e3/e3 and smβ1e3/e3 carotids and aorta (Figs. 6A–C and S14). Be-
cause elastin, in particular, exhibits autoﬂuorescence, we also per-
formed secondary controls for each of the primary antibodiesanalyzed (Fig. S15) as well as DAB immunohistochemical analysis
(data not shown).
Levels of extracellular matrix proteins were not found to be distinct
between mutant and control littermates, whereas organization of ECM
was clearly abnormal when in the absence of β1 integrin. The defects
Fig. 5. Differentiation of smooth muscle during development in the presence and absence of β1 integrin. Expression of A) sm22α, B) calponin and C) smooth muscle myosin heavy
chain (SMMHC) represented in red in α-smooth muscle actin (green) positive cells of the carotid at E15.5 and E18.5 and the dorsal aorta at E18.5. (topro=blue). Red box highlights
contrast between E18.5 β1e3/e3 carotids and smβ1e3/e3 carotids.
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exclusion of the descending aorta (Fig. 6). In particular, we found that
the organization of ECM lamellar structures is impaired in the absence
of β1 integrin. Review of the β1e3/e3 and ncβ1e3/e3 animals at E10.5
showed collagen IV and laminin are deposited and localize normallywithin some portions of the pharyngeal arch arteries, but that collagen
IV is reduced and laminin appears disorganized in regions of aneurysms
(Fig. S13).
β1 integrin has been shown to be critical for ﬁbrillogenesis of ﬁbro-
nectin in vitro (Wu et al., 1995), but a comparable effect in vivo has not
Fig. 6. Status of the ECM during development in the presence and absence of β1 integrin. Expression of A) ﬁbronectin, B) collagen IV and C) elastin represented in red in α-smooth
muscle actin (green) positive cells of the carotid at E15.5 and E18.5 and the dorsal aorta at E18.5. (topro=blue). Red box highlights contrast between E18.5 β1e3/e3 carotids and
smβ1e3/e3 carotids.
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is essential for the assembly of the ECM, particularly in ascending aorta,
carotids and brachiocephalic arteries. These defects lead to the develop-
ment of aneurysms and likely contribute to the lethality observed.
The degree of pathology in the aortic arch and carotids is dependent on
the timing of β1 integrin deletion
Our ﬁndings indicate that deletion of β1 integrin early in smooth
muscle differentiation affects the structure of the ECM in areas ofhigh stress. Whereas, deletion of this protein in smooth muscle pro-
genitors reveals contributions to aortic arch remodeling (Fig. 7A).
This phenotypic series is informative, in that it demonstrates the
value of different and overlapping Cre recombinases as well as varia-
tions in loxP constructs. It is also instructive on the role of β1 integrin
in pharyngeal arch remodeling. Further, assessing the timing of dele-
tion in relation to the outcomes together with previous published
work on the aortic arch enables detailed mapping of vessel assembly,
an important aspect of vascular development (Fig. 7B) (Hiruma et al.,
2002; Lindahl et al., 1997; Serbedzija et al., 1992).
Fig. 7. Schematic of the phenotypic series and process of vascular maturation. A) Schematic illustration of pharyngeal arch remodeling in wild type embryos (β1ﬂ/ﬂ and β1e3/e3) and
the phenotypes from the neural crest (ncβ1e3/e3) and smooth muscle (smβ1ﬂ/ﬂ and smβ1e3/e3) deletion of β1 integrin. B) Trichrome stained histological sections of β1e3/e3 and
smβ1e3/e3 embryos at E10.5, E15.5 and E18.5 with a timeline of pharyngeal arch/aortic arch developmental stages.
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Integrins have been shown to function in migration, regulate dif-
ferentiation, participate in the assembly of extracellular matrix and
serve as cellular mechanosensors (Abraham et al., 2008; Breau et al.,
2006; Carlson et al., 2008; Ingber, 2006; Li et al., 2003; Wu et al.,
1995; Xiao et al., 2007; Xiao et al., 2010). In this study we describe
the role of β1 integrin in differentiated vSMCs and in a subset of
vSMC progenitors. We discuss the contribution of different loxP
ﬂanked alleles and evaluate the outcome of β1 integrin deletion dur-
ing the assembly of the vascular wall.
Deletion of β1 integrin in smooth muscle resulted in a range of
aortic arch defects; however, the interrupted aortic arch was seen ex-
clusively in smβ1e3/e3 embryos. We predict that this is due to differ-
ences in recombination between the two models used. The short
distance between loxP sites in the β1e3 model yields a more efﬁcient
recombination than in the β1ﬂ transgenic mouse and the β1ﬂ allele
may create a pseudo-plasmid enabling expression after recombina-
tion (Turlo et al., 2010). This may also explain the difference between
phenotypes in the wnt1Cre (nc) mice. The persistence of some β1integrin positive smooth muscle cells in the media of the smβ1ﬂ/ﬂ at
E18.5 provides support to this concept. Regardless, the range of phe-
notypes in the different models highlights the signiﬁcance of timing
in relation to phenotypic outcomes and helps to identify distinct con-
tributions of β1 integrin at progressive developmental stages. The
embryonic lethality of the smβ1e3/e3 mice reported here uncovers
critical contributions of β1 integrin in aortic arch remodeling and vas-
cular wall assembly that were not revealed by deletion of β1 integrin
using the PDGFRβCre (Abraham et al., 2008). In that model live
knockouts were found as late as P(10) and inactivation of β1 integrin
resulted in discrete dilations in small caliber vessels combined with
adhesion defects, but no abnormalities were observed in large vessels
or aortic arch remodeling (Abraham et al., 2008). Along the same
lines, deletion of β1 integrin using the wnt1Cre resulted in greatly di-
verse phenotypes (β1ﬂ versus β1e3 model). While no vascular defects
were noted in the ncβ1ﬂ/ﬂ mouse; the ncβ1e3/e3 model resulted in
fully penetrant lethality by E12.5 due to hemorrhage in the aortic
arches. This range of outcomes provides a useful temporal framework
in which to identify essential roles of β1 integrin in vascular
development.
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absence of β1 integrin
The smooth muscle of the aortic arch and carotids originates from
the neural crest cells (Majesky, 2007). These progenitors migrate, dif-
ferentiate and proliferate as the pharyngeal arches undergo extensive
remodeling (Schwartz, 1997; Serbedzija et al., 1992). Previous work
by Breau and colleagues indicated that inactivation of β1 integrin in
neural crest (using the Ht-PA-Cre) resulted in a Hirschsprungs-like
phenotype due to migration defects in enteric neural crest cells
(Breau et al., 2006), but did not result in embryonic lethality. In con-
trast, we found that deletion of β1 integrin using Wnt1Cre in the β1e3
model (ncβ1e3/e3) was embryonic lethal due to defects in vessel wall
structure, but migration of vSMC progenitors was not affected. This
was a rather surprising result, as β1 integrin has been shown to im-
pair migration in other cell types in vivo. Thus it appears that smooth
muscle cells, or more likely their progenitors, utilize other receptors
for migration during development.
Initiation of differentiation towards the smooth muscle fate was
not blocked by lack of β1 integrin, but maintenance of some smooth
muscle cell speciﬁc proteins was affected. We evaluated three early
(α smooth muscle actin, SM22α, and SMMHC) and one late (calpo-
nin) proteins that are indicative of vSMC differentiation. Our ﬁndings
indicate that while α-smooth muscle actin was not affected by ab-
sence of β1 integrin; SMMHC, SM22α and calponin, in particular,
were reduced in smβ1e3/e3 at later time points, when compared to
controls. It is thought that integrins recognize the ECM and signal to
maintain contractile protein expression (Zargham et al., 2007). Our
data supports such a concept with some qualiﬁers, as not all contrac-
tile proteins were affected equally by absence of this integrin.Defects in vessel wall assembly and development of aneurysms
While β1 integrin expression was found throughout the entire
length of the aorta and major branches; incidence of aneurysms
upon deletion was restricted to the aortic arch and its immediate
branches. Similarly isolated defects of speciﬁc portions of the aorta
and its branches occurred in the deletion of TGFβ, with locations of
the defect depending on whether the deletion was partially penetrant
in all mesenchymal vSMCs or completely penetrant within the neural
crest (Choudhary et al., 2009). In our case, Western blots demonstrat-
ed an increase in β1 integrin expression in the aortic arch over the
descending dorsal aorta at E18.5 (Fig. 2D). This may explain why
these areas are more vulnerable to the loss of β1 integrin. They may
require greater amounts of β1 integrin as they experience high
shear-stress, as indicated by computer modeling of ﬂow in the carotid
and vascular branches in general (Huo et al., 2008; Meng et al., 2007;
Shojima et al., 2005). Further, the dilations seen in the ncβ1e3/e3 may
also correspond to areas of high shear-stress based the wall shear
stress diagrams in the pharyngeal arches of the chick (Wang et al.,
2009). The data indicates the cells migrate and differentiate, but
they are unable to support ﬂow in the pharyngeal arches, while the
dorsal aorta remains intact. These defects may occur earlier in the
ncβ1e3/e3 mouse as the cre recombinase targets a large population
of smooth muscle progenitors prior to differentiation and some
non-vSMCs as well.
Our early analysis of these dilations focused on the cellular com-
ponent that poses physical resistance to these forces (ie., smooth
muscle). However, we found no signiﬁcant changes in smooth muscle
cell number or ability to differentiate. Thus, we turned our evaluation
to the extracellular matrix components. In fact early studies indicate
that resistance to ﬂow in the great vessels relies heavily on ECM pro-
teins (Berry et al., 1975). This was supported by the fact that induced
SMC death by approximately 50% had little to no impact on vessel di-
ameter (Clarke et al., 2006), indicating that the ECM plays a criticalrole in the vessel wall by providing strength and resistance to repeat-
ed mechanical pressure.
Lessons from KO mice have indicated that the assembly of a com-
pliant vascular wall requires the organization of a complex lattice of
interacting proteins that include the adequate combination of ﬁbro-
nectin, ﬁbulin, ﬁbrillin, collagen, elastin and laminin (Wagenseil and
Mecham, 2009). Our data further reveals that β1 integrins are re-
quired for the assembly and appropriate organization of those pro-
teins into lamellar structures. These lattices ﬂank concentric layers
of smooth muscle cells; these, in turn, bind tightly to the organized
ECM enabling the formation of an integrated tissue specialized in dis-
tention and contraction. Absence of β1 integrins imposes a develop-
mental arrest in ECM assembly leading to structural defects in the
organization of the ECM lattices and resulting in the development of
aneurysms. Immunostaining of ECM at E15.5 carotids revealed that
matrix is laid down at similar levels and patterns in smβ1e3/e3 and
β1e3/e3 embryos. The discrepancy between the two groups becomes
noticeable only at E18.5 highlighting a previously unsuspected, but
critical contribution of β1 integrin in ECM architecture during vessel
differentiation.
Prior to the identiﬁcation of integrins, early observations showed
an alignment between ﬁbronectin and the cytoskeleton predicting
the existence of a molecule that linked the two (Hynes and Destree,
1978). Subsequent studies have served to conﬁrm the relationship
between integrins, assembly of ﬁbronectin as well as collagen ﬁbrils
(Li et al., 2003; van der Flier et al., 2010; Wu et al., 1995). Our ﬁndings
suggest that, in addition to ﬁbronectin, β1 integrins contribute to the
organization of several other matrix molecules. An alternative inter-
pretation is that the assembly of the ﬁbronectin ﬁbers provides the
early patterning or scaffold that serves as the foundation for addition-
al assembly of other matrix proteins.
The defects noted in smβ1e3/e3 mice are reminiscent of structural
failure due to absence of speciﬁc matrix proteins. For example, it
has been shown that mutations in ﬁbrillin-1 can result in large vessel
aneurysms (Mariko et al., 2011; Pereira et al., 1997). Fibrillin-1 con-
tributes to the construction of elastic ﬁbers, which participates in
the elastic recoil that aids in the maintenance of blood ﬂow
(Wagenseil and Mecham, 2009). A similar phenotype is also shared
by mice deﬁcient in ﬁbulin-4. These mice display ascending aortic an-
eurysms also thought to originate from defects in elastin assembly
(Huang et al., 2010). Here deletion of β1 integrin prevents the organi-
zation ECM proteins leading to aneurysms and indicate that this mol-
ecule is also critical to the functional compliance of the ECM in the
vessel wall. Overall these ﬁndings uncover a critical role for β1 integ-
rin in vascular matrix assembly and protection against the develop-
ment of aneurysms in the aortic arch and carotids.Conclusions
In deleting β1 integrin using an sm22αCre line, we sought to eval-
uate the consequences of loss of function at the onset of vascular or-
ganization. Contrary to expectations, β1 integrin was not required for
smooth muscle cell proliferation, migration or differentiation. Instead
we found that β1 integrin was speciﬁcally required in smooth muscle
cells for aortic arch remodeling and for the assembly of ECM proteins
within the vessel wall. Similar phenotypes have been identiﬁed in
mice lacking speciﬁc ECMmolecules. Evaluation of the ECM in mutant
mice indicates similar level of deposition, but lack of lamellar organi-
zation. Overall these ﬁndings support an essential role for β1 integrin
in matrix assembly that is critical for vascular function. A nuance of
the phenotype is that the effect was restricted to the ascending
aorta, aortic arch and carotid arteries. The reason for this regional re-
striction is unclear our speculation is that the aortic arch and carotids
require higher demands in ECM assembly that are incompatible with
the absence β1 integrin.
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